Home » Topics » Regulatory

Regulatory
RSS

FDA approves Opsumit for PAH

Oct. 21, 2013

FDA approves Novoeight for use in adults and children with hemophilia A

Oct. 17, 2013

Duavee approved for vasomotor symptoms and preventing postmenopausal osteoporosis

Oct. 4, 2013

Jublia approved in Canada for the treatment of onychomycosis

Oct. 4, 2013

FDA grants accelerated approval of new indication for Perjeta

Oct. 2, 2013

FDA approves vortioxetine for major depressive disorder

Oct. 1, 2013

FDA approves Cimzia for treatment of active psoriatic arthritis

Oct. 1, 2013

Simeprevir obtains first approval in Japan

Sep. 27, 2013

First approval in Europe for Gilead Sciences' cobicistat

Sep. 26, 2013

Bayer receives Canadian approval for riociguat in thromboembolic pulmonary hypertension

Sep. 26, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 25, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026